In the quest to outshine the broader market, stock pickers diligently seek out stocks with the potential for superior performance. Making the right choices can significantly elevate your wealth.
The closing price of Moderna Inc (NASDAQ: MRNA) was $39.59 for the day, up 0.51% from the previous closing price of $39.39. In other words, the price has increased by $0.51 from its previous closing price. On the day, 5.1 million shares were traded. MRNA stock price reached its highest trading level at $40.3399 during the session, while it also had its lowest trading level at $38.52.
Ratios:
Our analysis of MRNA’s different ratios will help us gain a deeper understanding of the company. For the most recent quarter (mrq), Quick Ratio is recorded 4.20 and its Current Ratio is at 4.39. In the meantime, Its Debt-to-Equity ratio is 0.11 whereas as Long-Term Debt/Eq ratio is at 0.11.
On November 19, 2024, Berenberg started tracking the stock assigning a Hold rating and target price of $42.Berenberg initiated its Hold rating on November 19, 2024, with a $42 target price.
Insider Transactions:
Also, insider trades can serve as a great indicator of what management thinks about the future direction of a stock’s price. A recent insider transaction in this stock occurred on Dec 09 ’24 when Klinger Shannon Thyme sold 529 shares for $44.68 per share. The transaction valued at 23,637 led to the insider holds 20,446 shares of the business.
Klinger Shannon Thyme bought 529 shares of MRNA for $23,637 on Dec 09 ’24. On Dec 03 ’24, another insider, Klinger Shannon Thyme, who serves as the Chief Legal Officer of the company, sold 112 shares for $43.30 each. As a result, the insider received 4,849 and left with 19,837 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, MRNA now has a Market Capitalization of 15234944000 and an Enterprise Value of 9645973504. For the stock, the TTM Price-to-Sale (P/S) ratio is 2.99 while its Price-to-Book (P/B) ratio in mrq is 1.28. Its current Enterprise Value per Revenue stands at 1.898 whereas that against EBITDA is -4.084.
Stock Price History:
Over the past 52 weeks, MRNA has reached a high of $170.47, while it has fallen to a 52-week low of $35.80. The 50-Day Moving Average of the stock is -14.59%, while the 200-Day Moving Average is calculated to be -56.49%.
Shares Statistics:
MRNA traded an average of 7.53M shares per day over the past three months and 9933610 shares per day over the past ten days. A total of 385.00M shares are outstanding, with a floating share count of 343.19M. Insiders hold about 10.82% of the company’s shares, while institutions hold 67.52% stake in the company. Shares short for MRNA as of 1732838400 were 40837234 with a Short Ratio of 5.42, compared to 1730332800 on 34383773. Therefore, it implies a Short% of Shares Outstanding of 40837234 and a Short% of Float of 13.96.
